A phase III randomized double-blind study of ceftobiprole versus comparator in the treatment of nosocomial pneumonia
Latest Information Update: 07 Apr 2022
Price :
$35 *
At a glance
- Drugs Ceftobiprole medocaril (Primary) ; Ceftazidime; Linezolid
- Indications Nosocomial pneumonia; Ventilator associated pneumonia
- Focus Registrational; Therapeutic Use
- Acronyms CHOPIN; CHOPIN-1; CHOPIN-2
- Sponsors Basilea Pharmaceutica; Janssen Research & Development
- 15 Apr 2016 According to a Basilea Pharmaceutica media release, results of pooled post hoc analysis from four phase III studies four double-blind, randomized, phase 3 studies in complicated skin or pulmonary infections were presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
- 12 Apr 2016 Results (post-hoc pooled analysis of this and other three studies, n = 3031) assessing clinical cure and mortality presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases.
- 21 Sep 2015 Post hoc analysis results (n= 571) of this trial presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy